P Steuber

658 total citations
16 papers, 481 citations indexed

About

P Steuber is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, P Steuber has authored 16 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in P Steuber's work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). P Steuber is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). P Steuber collaborates with scholars based in United States, Canada and Netherlands. P Steuber's co-authors include Jonathan J. Shuster, Michael J. Borowitz, F G Behm, Andrew J. Carroll, David Head, Michael P. Link, WM Crist, A H Ragab, J. Jackson and Curt I. Civin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

P Steuber

16 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Steuber United States 11 292 257 121 97 90 16 481
Nicola C. Venn Australia 15 438 1.5× 368 1.4× 191 1.6× 66 0.7× 150 1.7× 32 658
Rüdiger Fengler Germany 8 287 1.0× 193 0.8× 197 1.6× 29 0.3× 63 0.7× 11 440
Paul Bowman United States 10 156 0.5× 169 0.7× 69 0.6× 72 0.7× 89 1.0× 22 388
Mieke Aldenhoven Netherlands 9 66 0.2× 129 0.5× 37 0.3× 104 1.1× 64 0.7× 17 534
Blanca López‐Ibor Spain 11 111 0.4× 72 0.3× 65 0.5× 47 0.5× 79 0.9× 29 289
Anna Evans United Kingdom 7 157 0.5× 310 1.2× 61 0.5× 103 1.1× 164 1.8× 10 470
Beth Blackwell United States 8 33 0.1× 81 0.3× 42 0.3× 78 0.8× 49 0.5× 9 489
Giulia Mariani Italy 12 223 0.8× 52 0.2× 95 0.8× 19 0.2× 90 1.0× 28 660
Nicoletta Masera Italy 14 41 0.1× 236 0.9× 138 1.1× 246 2.5× 108 1.2× 37 547
J E Freeman United Kingdom 5 109 0.4× 67 0.3× 40 0.3× 94 1.0× 18 0.2× 8 268

Countries citing papers authored by P Steuber

Since Specialization
Citations

This map shows the geographic impact of P Steuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Steuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Steuber more than expected).

Fields of papers citing papers by P Steuber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Steuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Steuber. The network helps show where P Steuber may publish in the future.

Co-authorship network of co-authors of P Steuber

This figure shows the co-authorship network connecting the top 25 collaborators of P Steuber. A scholar is included among the top collaborators of P Steuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Steuber. P Steuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Allen, Carl E., Kala Y. Kamdar, Stephen J. Simko, et al.. (2013). Pediatric Burkitt's Lymphoma and Diffuse B-Cell Lymphoma: Are Surveillance Scans Required?. Pediatric Hematology and Oncology. 31(3). 253–257. 15 indexed citations
2.
Rathore, N., Judith Margolin, Terzah M. Horton, et al.. (2012). Pediatric Hodgkin Lymphoma: Are We Over-scanning Our Patients?. Pediatric Hematology and Oncology. 29(5). 415–423. 19 indexed citations
3.
Graham, Michael L., Jonathan J. Shuster, B A Kamen, et al.. (1996). Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.. PubMed. 2(2). 331–7. 14 indexed citations
4.
Camitta, Bruce M., Donald H. Mahoney, Brigid G. Leventhal, et al.. (1994). Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.. Journal of Clinical Oncology. 12(7). 1383–1389. 66 indexed citations
5.
Borowitz, Michael J., Andrew J. Carroll, Jonathan J. Shuster, et al.. (1993). Use of Clinical and Laboratory Features to Define Prognostic Subgroups in B-Precursor Acute Lymphoblastic Leukemia: Experience of the Pediatric Oncology Group. Recent results in cancer research. 131. 257–267. 9 indexed citations
6.
Koehler, María, F G Behm, Jonathan J. Shuster, et al.. (1993). Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: a Pediatric Oncology Group study.. PubMed. 7(12). 2064–8. 14 indexed citations
7.
Crist, W M, J J Shuster, Thomas Look, et al.. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia. 6. 162–165. 28 indexed citations
8.
Crist, WM, Jonathan J. Shuster, Thomas Look, et al.. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.. PubMed. 6 Suppl 2. 162–6. 8 indexed citations
9.
Weinstein, Harel, Y. Ravindranath, J. Krischer, et al.. (1992). The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).. PubMed. 6 Suppl 2. 52–4. 5 indexed citations
10.
Krizman, David B., Joseph Jankovic, P Steuber, et al.. (1991). 9p monosomy in a patient with Gilles de la Tourette's syndrome. Neurology. 41(9). 1513–1513. 35 indexed citations
11.
Vogelstein, Bert, Curt I. Civin, Antonette C. Preisinger, et al.. (1990). RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study. Genes Chromosomes and Cancer. 2(2). 159–162. 36 indexed citations
12.
Crist, W.M., Andrew J. Carroll, Jonathan J. Shuster, et al.. (1990). Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood. 76(3). 489–494. 5 indexed citations
13.
Crist, WM, Andrew J. Carroll, Jonathan J. Shuster, et al.. (1990). Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood. 76(3). 489–494. 171 indexed citations
14.
Hakami, Nasrollah, A. Thomas Look, P Steuber, et al.. (1987). Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study.. Journal of Clinical Oncology. 5(7). 1022–1025. 23 indexed citations
15.
16.
Steuber, P, et al.. (1981). Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study.. PubMed. 3(3). 301–3. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola C. Venn Breakdown of academic impact, for papers by Rüdiger Fengler Breakdown of academic impact, for papers by Paul Bowman Breakdown of academic impact, for papers by Mieke Aldenhoven Breakdown of academic impact, for papers by Blanca López‐Ibor Breakdown of academic impact, for papers by Anna Evans Breakdown of academic impact, for papers by Beth Blackwell Breakdown of academic impact, for papers by Giulia Mariani Breakdown of academic impact, for papers by Nicoletta Masera Breakdown of academic impact, for papers by J E Freeman
Rankless by CCL
2026